It appears more money will go toward the direction of China. VC money is nothing new and in another post there were 2 VCs duking it out over their investments. Last year as well in somewhat of a landmark decision, the FDA accepted and was trusting of Chinese Clinical Trial data. 
Columbia Pacific, a Seattle investment firm has also invested in building a chain of hospitals in China and other Asian countries as well, reported back in August of 2008 at a time here in the US where we are struggling to keep hospitals open.
Chinese MRIs, Coming to Your Hospital
The Health Insurance carriers are already there taking up a stake in the potential business as well.
WellPoint settles Calif. lawsuit and Who’s going to China?
The stake in money for healthcare has been evolving for a while and now with healthcare reform it appears to be growing. BD
Last week, China’s State Council approved sweeping reform of its health care system, infusing it with $125 billion to provide universal medical coverage by 2011. And already venture capitalists all over the world are anticipating the opportunities in life science fields — pharmaceuticals, device making, etc. — that this avalanche of new funding will make possible.
Most of the investors that stand to benefit are based in China — Qiming Ventures and Shenzhen Capital Group prime among them. But Asian branches of major American firms are also looking for a slice of the pie — with Sequoia Capital China, Intel Capital and biotech focused MPM Capital leading the charge. MPM already took part in the $37 million round for Taipei-based Taigen Biotechnology, one of the four Chinese health companies that has taken capital so far this year.
VCs already eyeing potential in new Chinese health care reforms » VentureBeat
Related Reading:
0 comments :
Post a Comment